Table 1.
Characteristics of 93 patients with urothelial bladder carcinoma treated with radical cystecomy and bilateral lymphadenectomy
| Characteristic | No. (%) |
|---|---|
| Total |
93 (100.0) |
| Median age (range) |
63 (34 – 79) |
| Sex | |
| Men |
79 (84.9%) |
| Women |
14 (15.1%) |
| Pathological T stage | |
| T1* |
4 (4.3%) |
| T2 |
15 (16.1%) |
| T3 |
52 (55.9%) |
| T4 |
22 (23.7%) |
| Pathological N stage | |
| Node negative |
61 (65.6%) |
| Node positive |
32 (34.4%) |
| Histologic type | |
| Squamous differentiation |
11 (11.8%) |
| Other types |
82 (88.2%) |
| Pathological grade† | |
| G2 |
10 (10.8%) |
| G3 |
83 (89.2%) |
| ERCC1 expression | |
| Positive |
54 (58.1%) |
| Negative |
39 (41.9%) |
| Adjuvant chemotherapy (gemcitabine plus cisplatin) | |
| Yes |
57 (61.3%) |
| 4 cycles |
24 (25.8%) |
| 3 cycles |
28 (30.1%) |
| 2 cycles |
4 (4.3%) |
| 1 cycle |
1 (1.1%) |
| No | 36 (38.7%) |
*all patients have metastatic lymph nodes. † 1973 WHO grading.